Cargando…

Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome

Barth syndrome (BTHS) is a cardiomyopathy caused by the loss of tafazzin, a mitochondrial acyltransferase involved in the maturation of the glycerophospholipid cardiolipin. It has remained enigmatic as to why a systemic loss of cardiolipin leads to cardiomyopathy. Using a genetic ablation of tafazzi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dudek, Jan, Cheng, I‐Fen, Chowdhury, Arpita, Wozny, Katharina, Balleininger, Martina, Reinhold, Robert, Grunau, Silke, Callegari, Sylvie, Toischer, Karl, Wanders, Ronald JA, Hasenfuß, Gerd, Brügger, Britta, Guan, Kaomei, Rehling, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734842/
https://www.ncbi.nlm.nih.gov/pubmed/26697888
http://dx.doi.org/10.15252/emmm.201505644
Descripción
Sumario:Barth syndrome (BTHS) is a cardiomyopathy caused by the loss of tafazzin, a mitochondrial acyltransferase involved in the maturation of the glycerophospholipid cardiolipin. It has remained enigmatic as to why a systemic loss of cardiolipin leads to cardiomyopathy. Using a genetic ablation of tafazzin function in the BTHS mouse model, we identified severe structural changes in respiratory chain supercomplexes at a pre‐onset stage of the disease. This reorganization of supercomplexes was specific to cardiac tissue and could be recapitulated in cardiomyocytes derived from BTHS patients. Moreover, our analyses demonstrate a cardiac‐specific loss of succinate dehydrogenase (SDH), an enzyme linking the respiratory chain with the tricarboxylic acid cycle. As a similar defect of SDH is apparent in patient cell‐derived cardiomyocytes, we conclude that these defects represent a molecular basis for the cardiac pathology in Barth syndrome.